Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people asking this question want a straight answer, so here it is: based on clinical trial data, losing 10kg on Mounjaro typically takes somewhere between 12 and 24 weeks, depending on your starting weight, the dose you reach, and how your body responds. That range is real, not a hedge — individual results genuinely vary that much. Mounjaro (tirzepatide) is a prescription-only weight-loss treatment licensed in the UK for adults with a BMI of 30 or above, or 27 or above with a weight-related condition. A prescriber assesses suitability before any treatment begins; the timelines below reflect what the evidence shows across a population, not a guarantee for any individual.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults over 72 weeks. Participants on the 10mg and 15mg doses saw average body-weight reductions of around 19–21%. Translated into absolute kilograms, someone who began the trial at 105kg and reached the 15mg dose had lost roughly 21kg by week 72 on average, so 10kg would, in that scenario, have been crossed somewhere around the midpoint of the study, broadly weeks 20–28.
That said, the trial recorded faster losses in the earlier weeks for many participants once the dose climbed above 5mg, because that is when appetite suppression becomes most noticeable. Weight loss is rarely linear. Many people describe little change in the first month while the body adjusts to the 2.5mg starter dose, then a more pronounced shift from month two or three onward. If you want a fuller sense of when Mounjaro begins to have an effect, that timeline is worth understanding before setting expectations around a specific kilogram target.
NICE's appraisal of tirzepatide (TA1026) notes that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed. For a 10kg target, reaching that threshold in six months confirms the medicine is working for you, most people who respond do so well within that window.
Yes, substantially. Weight loss on Mounjaro is reported as a percentage of starting body weight, which means the heavier you start, the faster 10kg arrives in absolute terms, even if your percentage loss rate is identical to someone lighter.
Take two people. One starts at 120kg. A 10kg loss is 8.3% of their starting weight. Based on SURMOUNT-1 data, many participants at that starting weight crossed the 8% mark within 16–20 weeks on an escalating dose. The second person starts at 85kg. Their 10kg represents nearly 12% of body weight. That same percentage milestone took longer in the trial (often 24–30 weeks) even for strong responders.
This is also why questions like how long it takes to lose 2 stone (12.7kg) or 3 stone (19kg) carry different answers that are still grounded in the same percentage-based evidence. A stone-based or kilogram-based target only becomes meaningful once you know your own starting point and the dose trajectory your prescriber plans.
The rate can also slow if you plateau, which is common around months four to six. A plateau is not failure. It often reflects the body stabilising before the next dose increase takes effect, or a point where dietary habits need recalibrating with your clinical team.
This is the variable most people underestimate. Mounjaro's licensed schedule begins at 2.5mg, a dose designed to settle your digestive system, not to produce maximum weight loss. From there, doses increase roughly every four weeks: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and up to 15mg. Each step is a clinical decision, not automatic.
The practical consequence is that the weight loss curve tends to steepen as the dose increases. Someone who reaches 10mg or 12.5mg by week 16 typically has a noticeably different trajectory from someone who stays at 7.5mg for longer because of gastrointestinal side effects. Speed of titration depends on tolerability, not willingness.
This is also relevant to cost. If you are weighing up how long treatment is likely to run before you reach your goal, the dose progression affects how many months of treatment that involves. Understanding the full picture before you start is useful. Our weight-loss treatment overview sets out what the journey typically looks like from consultation to ongoing clinical support.
Worth knowing practically: when your first pen arrives via DPD in plain, unbranded packaging, it contains your starting dose, ready to use. The pen is pre-filled and pre-set; no measuring, no mixing.
Mounjaro's UK licence specifies use alongside a reduced-calorie diet and increased physical activity, not as a standalone intervention. That framing exists because the trial data was generated with those conditions in place. In practice, the medicine lowers appetite significantly, which makes eating less easier for many people, but the composition of what you eat still matters.
Adequate protein intake (typically 1.2–1.6g per kilogram of body weight daily) helps preserve muscle mass as weight falls, which matters for metabolism and physical function. Fibre supports gut health and satiety. Hydration becomes especially relevant because gastrointestinal side effects (nausea, loose stools) can reduce fluid intake; staying hydrated helps manage those effects too.
For guidance specific to your situation, a prescriber or dietitian is the right person to talk to. General diet advice from the NHS Live Well healthy weight pages is a reasonable starting point while you wait for a clinical consultation. Strength or resistance exercise two to three times a week is worth prioritising over exclusively cardio-based activity, because it preserves the muscle that weight loss can otherwise reduce. None of this shortens the titration schedule, but it does influence how quickly the dose at any given level translates into kilogram loss on the scales.
If a 10kg target is just the first milestone and a larger goal follows, what the evidence shows for 20kg is a natural next read. And if you are ready to find out whether you are clinically suitable to start, a free consultation with our prescribers is the place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.